[go: up one dir, main page]

SU105577A1 - The method of obtaining the drug galascorbine - Google Patents

The method of obtaining the drug galascorbine

Info

Publication number
SU105577A1
SU105577A1 SU454356A SU454356A SU105577A1 SU 105577 A1 SU105577 A1 SU 105577A1 SU 454356 A SU454356 A SU 454356A SU 454356 A SU454356 A SU 454356A SU 105577 A1 SU105577 A1 SU 105577A1
Authority
SU
USSR - Soviet Union
Prior art keywords
drug
galascorbine
obtaining
weight
solution
Prior art date
Application number
SU454356A
Other languages
Russian (ru)
Inventor
Е.Ф. Шамрай
Original Assignee
Е.Ф. Шамрай
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Е.Ф. Шамрай filed Critical Е.Ф. Шамрай
Priority to SU454356A priority Critical patent/SU105577A1/en
Application granted granted Critical
Publication of SU105577A1 publication Critical patent/SU105577A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

Предлагаетс  , способ получени  препарата галаскорбин дл  лечени  ;:ociiOB у рожениц.A method is proposed for preparing galascorbine for the treatment of:: ociiOB in laboring women.

Cii)L4)6 заключаетс  в том, что 1 нес. ч. аскорбиновой кислоты, 3 i;ec. ч. лшдицпнсь-ого танннна и .5 нес. ч. едкого кали  раствор ют i; 1.0 вес. ч. воды. Полученный раствор упаривают, сушат и растиf;;UOT , ПОрОШО.;.Cii) L4) 6 is that 1 carried. including ascorbic acid, 3 i; ec. h lshditspns oh tannnna and .5 carried. including caustic potash, dissolve i; 1.0 weight h of water. The resulting solution is evaporated, dried and grown; f ;; UOT, IT.;.

Прсмтарат г)едставл ет собой сочетание виталипгов С и Р и нриме}1 етс  ;аи наружное средство дл  .печени  сосков у рожениц.Prsmratrat g) is a combination of vitalipus C and P and nrime} 1a; ai is an external means for nipple premature in childbirth.

Перед унотреблением 1 г нренарата раствор ют i; стакане дистил .ифован юй воды. В нолучеином растворе смачивают марлевую салфетку , которую накладывают на больной сосок. Салфетку по мере ысьханБЯ ироп1ают из пнпетни iiriCTiiopoM и смен ют через ка;-кдыеBefore consumption, 1 g of nrenarate is dissolved i; A glass of distilled water. In nolucheynom solution moisten gauze napkin, which impose on the patient nipple. The napkin is scaled from the second, iiriCTiiopoM, and replaced with ka;

5 - 6 часов. Раствор со.храи ет CHOIJ терапевтичеотне свойства на фот женпн 1 суток.5 - 6 hours. The solution compresses the CHOIJ therapeutic properties on the photo for 1 day.

Препарат галаскорбин разрешен К нрил1ене И1Ю 35арма1;олоп1ческн; г hoi HiTeTOJ Учеиого Совета Министерства здравоохранени  СССР.The drug galascorbine is allowed to nil1ene I1Yu 35arm1; olop1icschen; Mr. Hoi HiTeTOJ The Council of the Ministry of Health of the USSR.

Предмет изо б р о ген ii v.The subject is a gene ii v.

Claims (2)

1.Способ пол ченн  препарата га.часкорбпи. а т /i л ч а in n i; о   . что 1 вес. ч. аскорбниовой кнслоты . 3 вес. ч. .лгединннского iriHннна н 1,5 вес. ч. едкого ьа.чи  раствор ют в 10 вес. ч. воды, полуieiHHiHi раствор упарнвают, сушатi: растирают в порошок.1. The method of preparation of the drug ga. Chaskorbi. a t / i lh and in n i; about . that 1 weight. h. ascorbnic knsloty. 3 wt. h. lededinnskogo iriHnnna n 1.5 weight. ca. ca. ca. dissolve in 10 wt. including water, semi-iHHiHi solution is evaporated, dried: pound into a powder. 2.Применение нрепарата по п. 1 дл  леченн  трендин сос1лон у ро кениц . ьак наружное средство.2. The use of the drug of claim 1 for treatment of trending individuals in roenitz. How is an external remedy.
SU454356A 1953-10-28 1953-10-28 The method of obtaining the drug galascorbine SU105577A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SU454356A SU105577A1 (en) 1953-10-28 1953-10-28 The method of obtaining the drug galascorbine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SU454356A SU105577A1 (en) 1953-10-28 1953-10-28 The method of obtaining the drug galascorbine

Publications (1)

Publication Number Publication Date
SU105577A1 true SU105577A1 (en) 1956-11-30

Family

ID=48378965

Family Applications (1)

Application Number Title Priority Date Filing Date
SU454356A SU105577A1 (en) 1953-10-28 1953-10-28 The method of obtaining the drug galascorbine

Country Status (1)

Country Link
SU (1) SU105577A1 (en)

Similar Documents

Publication Publication Date Title
Pyle et al. Contact dermatitis from penicillin
JPS57212114A (en) Capsule containing allergen activator and preparation therefor
ES417377A1 (en) Salt of S-adenosil-L-methionine and process of preparation
SU105577A1 (en) The method of obtaining the drug galascorbine
Callison et al. Abnormalities of the eye occurring in young vitamin E-deficient rats
Franks et al. Cutaneous blastomycosis complicated by meningitis
Burt et al. Metabolic activity of oxytocin in the puerperium
Powell The inhibitory effect of 9: 10-phenanthraquinone upon tumour growth in mice
Larks et al. Electrical activity of oviducts in vivo
SU150581A1 (en) The method of obtaining therapeutic drug Vipratox
Wade A case of myotonia congenita with hypothyroidism
Greenberg et al. Epididymitis associated with typhoid
Khasanov Polyneuritis due to alimentary poisoning with Davydov's drug
SU68443A1 (en) Method of treating skin cancers
SU69584A1 (en) Method of treating streptococcal infections
GB1030605A (en) Calcitonin, a blood-calcium reducer
STRAUCH Repository Injections: How to Obtain Lasting Effects With Injected Water-Soluble Medicaments Such as Insulin and Epinephrine
Grinberg ENDOCRINE EXCHANGE DISORDERS IN SPINAL CORD TUMORS
SU110648A1 (en) Wound Healing
SU66137A1 (en) The method of obtaining a therapeutic drug
SU295301A1 (en) METHOD OF OBTAINING AQUEOUS SOLUTIONS OF LEBORIN
SU141820A1 (en) A method for treating cattle for trichomoniasis using a mixture of tripafl wine and sodium citrate
SU709068A1 (en) Method of inhibiting the contraction activity of womb
SU9906A1 (en) The method of obtaining a stable, sterile sterilized therapeutic complex solution of sodium gold thiosulfate
AT100211B (en) Process for the preparation of new organic arsenic compounds.